Literature DB >> 26853922

Problems and health needs of adult extracorporeal membrane oxygenation patients following hospital discharge: A qualitative study.

Kang-Hua Chen1, Feng-Chun Tsai2, Chien-Sung Tsai3, Shu-Ling Yeh4, Li-Chueh Weng1, Li-Chyun Yeh5.   

Abstract

OBJECTIVES: To explore problems and health needs of adult extracorporeal membrane oxygenation (ECMO) patients during a one-year period following hospital discharge.
BACKGROUND: ECMO functions as life support during treatment of advanced cardiac and respiratory failure. Knowledge regarding the problems and health needs of discharged adult patients who have undergone ECMO is lacking.
METHODS: This study used a qualitative descriptive interview design. Fourteen adult ECMO patients were recruited by purposive sampling prior to discharge. Data were generated from semi-structure in-depth interviews at 3-month intervals following hospital discharge.
RESULTS: Four themes described problems and needs post-discharge: stress resulting from ECMO surgery; making health a priority; support from family friends and health care professionals; and emotional support.
CONCLUSIONS: Multidisciplinary evidence-based interventions should be implemented prior to or soon after discharge to help with the physical, psychological and social problems that ECMO survivors experience, which can help improve their quality of life.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extracorporeal membrane oxygenation; Health needs; Physical problem; Psychosocial problem; Qualitative study

Mesh:

Year:  2016        PMID: 26853922     DOI: 10.1016/j.hrtlng.2015.12.005

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  7 in total

Review 1.  The Role and Impact of Extracorporeal Membrane Oxygenation in Critical Care.

Authors:  Iqbal Ratnani; Divina Tuazon; Asma Zainab; Faisal Uddin
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Apr-Jun

2.  In-patient physiotherapy for adults on veno-venous extracorporeal membrane oxygenation - United Kingdom ECMO Physiotherapy Network: A consensus agreement for best practice.

Authors:  Allaina Eden; Claire Purkiss; Gabriella Cork; Adam Baddeley; Kelly Morris; Leah Carey; Mike Brown; Laura McGarrigle; Samantha Kennedy
Journal:  J Intensive Care Soc       Date:  2017-06-14

Review 3.  Quality of life following adult veno-venous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review.

Authors:  E R Kurniawati; V G H Rutjens; N P A Vranken; T S R Delnoij; R Lorusso; I C C van der Horst; J G Maessen; P W Weerwind
Journal:  Qual Life Res       Date:  2021-04-07       Impact factor: 4.147

4.  Long-term survival and health-related quality of life in patients with severe acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation support.

Authors:  Jonathan Rilinger; Klara Krötzsch; Xavier Bemtgen; Markus Jäckel; Viviane Zotzmann; Corinna N Lang; Klaus Kaier; Daniel Duerschmied; Alexander Supady; Christoph Bode; Dawid L Staudacher; Tobias Wengenmayer
Journal:  Crit Care       Date:  2021-11-29       Impact factor: 9.097

5.  Changes in quality of life and health status in patients with extracorporeal life support: A prospective longitudinal study.

Authors:  Kang-Hua Chen; Yu-Ting Chen; Shu-Ling Yeh; Li-Chueh Weng; Feng-Chun Tsai
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

6.  The Need for Extracorporeal Membrane Oxygenation in Adults Undergoing Congenital Heart Surgery: Impact and Trends of Utilization.

Authors:  Salvatore Aiello; Rohit S Loomba; Connor Kriz; Matthew Buelow; Saurabh Aggarwal; Rohit R Arora
Journal:  Indian J Crit Care Med       Date:  2017-09

7.  Post-Discharge Depression Status for Survivors of Extracorporeal Membrane Oxygenation (ECMO): Comparison of Veno-Venous ECMO and Veno-Arterial ECMO.

Authors:  Wan-Jung Lin; Yu-Ling Chang; Li-Chueh Weng; Feng-Chun Tsai; Huei-Chiun Huang; Shu-Ling Yeh; Kang-Hua Chen
Journal:  Int J Environ Res Public Health       Date:  2022-03-11       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.